Diagnosis and Treatment

Drug That Harnesses Body's Own Immune System Produces Lasting Remissions For Melanoma Patients

Written By Deena Beasley, Reuters

Mar 3 (Reuters) - A drug that uses the body's own immune system to kill cancer cells has produced lasting remissions - some as long as two years - in patients with melanoma that had spread to other parts of the body, according to data published on Monday.

Follow-up from an early-stage, 107-patient trial of the drug, Bristol-Myers Squibb's nivolumab, found that a year after treatment, 62 percent of patients were alive. After two years, 43 percent were alive.

Cancer deaths rise to 8.2 million, breast cancer sharply up

The global death toll from cancer rose to 8.2 million in 2012 with sharp rises in breast cancer as the disease tightened its grip in developing nations struggling to treat an illness driven by Western lifestyles.

Cancer deaths were up 8 percent from 7.6 million in a previous survey in 2008 and breast cancer killed 522,000 women last year, up 14 percent in the same period, according to the World Health Organisation's International Agency for Research on Cancer (IARC).

Fran on Anderson - Fran Talks About Her Cancer Misdiagnosis

On the April 16, 2004, episode of ANDERSON, Fran opened up to Anderson Cooper about her battle with cancer, saying she was misdiagnosed by eight doctors in a two-year period. "By the grace of God I was still in stage one. I was misdiagnosed for a peri-menopausal condition that I didn't have because at uterine cancer's earliest stage, it kind of mimics that. I was lucky because uterine cancer is a very slow growing cancer," Drescher explained.

Nanostars Deliver Cancer Drugs Direct To Nucleus

Scientists at Northwestern University in the US have developed a simple, specialized, star-shaped gold nanoparticle that can deliver drugs directly to the nucleus of a cancer cell. They write about their work in a paper published recently in the journal ACS Nano.

Senior author Dr Teri W. Odom, said in a statement released on Thursday:

"Our drug-loaded gold nanostars are tiny hitchhikers."

Cancer: New Science on How to Prevent and Treat It—A Report from TEDMED

CONVENTIONAL MEDICINE HAS LOST THE BATTLE WITH CANCER. But that doesn’t mean the war is over. Let me explain why we may finally be heading in the right direction.

I just returned from TEDMED, an extraordinary gathering of brilliant minds from science, medicine, business, and technology—a veritable intellectual orgy. During the conference, there was a theme that emerged: Synthesis.

Brain-cancer device now FDA-approved

Brain tumors may soon encounter a new weapon. The Food and Drug Administration has approved a new device that uses electrical energy to kill brain cancer cells. The device, approved for those who have malignant tumors known as glioblastoma multiforme, adds a potential new alternative to chemotherapy for patients with advanced brain tumors.

Yearly Mammograms from Age 40 Save 71 Percent More Lives, Study Shows

ScienceDaily (Jan. 27, 2011) — A new study questions the controversial U.S. Preventative Service Task Force recommendations for breast cancer screening, with data that shows starting at a younger age and screening more frequently will result in more lives saved.

Cancer Costs Predicted to Skyrocket to $158 Billion by 2020

Karin Gaines of Rockford, Ill., is battling breast cancer for the second time in her life. She's taking two different medications to treat her disease, which also has spread to her bones.

Pages